The pregnyl market research report is one of a series of new reports that provides pregnyl market statistics, including the pregnyl industry's global market size, regional shares, competitors with a pregnyl market share, detailed pregnyl market segments, market trends and opportunities, and any further data you may need to thrive in the pregnyl industry. This pregnyl market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to increasing infertility rates, rising demand for assisted reproductive technologies, growing awareness of hormonal disorders, expanding healthcare access in emerging markets, rising adoption of hCG for male fertility, and rising healthcare expenditure. Major trends in the forecast period include advancements in formulation, advancements in drug delivery systems, advancements in dosage precision, innovation in combination therapies, integration of patient-friendly packaging, and adoption of telemedicine for remote fertility management.
The increasing prevalence of male hypogonadism is expected to contribute to the growth of the pregnyl market. Male hypogonadism is a condition where the body does not produce enough testosterone, a hormone crucial for male growth and development, or sufficient sperm. This condition is becoming more common due to factors such as aging populations, higher rates of obesity, and exposure to environmental toxins. Pregnyl helps manage male hypogonadism by providing human chorionic gonadotropin (hCG), which stimulates the testes to produce testosterone and support spermatogenesis, addressing hormonal imbalances, improving testosterone levels, and restoring fertility in men. For example, the Endocrine Society reported in January 2022 that approximately 35% of men over the age of 45 and 30-50% of men with obesity or type 2 diabetes experience hypogonadism. This rise in male hypogonadism is thus driving the growth of the Pregnyl market.
The increasing prevalence of infertility is also expected to drive growth in the pregnyl market. Infertility is defined as the inability to achieve pregnancy after one year of regular, unprotected intercourse. Factors such as lifestyle changes, environmental pollutants, and delayed childbearing are contributing to the growing rates of infertility. Pregnyl helps in infertility treatment by providing hCG, which stimulates ovulation in women and supports sperm production in men, enhancing reproductive function and increasing the chances of conception for those struggling with infertility. The World Health Organization reported in April 2023 that about 17.5% of the global adult population, or roughly 1 in 6 people, experience infertility. As infertility rates continue to rise, the demand for Pregnyl is expected to increase.
The expansion of healthcare infrastructure is another key factor driving the growth of the pregnyl market. Healthcare infrastructure encompasses the physical and organizational resources, facilities, and systems necessary to deliver healthcare services. This expansion is largely driven by the aging population, the rise in chronic diseases, and advancements in technology. A strong healthcare infrastructure ensures access to fertility treatments, proper storage, and administration facilities, as well as trained healthcare professionals. For example, the American Hospital Association reported in January 2024 that the United States had 6,120 hospitals with 916,752 staffed beds and 33,679,935 total admissions in 2024. In addition, the Office for National Statistics noted in May 2024 that healthcare expenditure in the UK rose by 5.6% in nominal terms from 2022 to 2023. As healthcare infrastructure continues to grow, it supports the accessibility and use of Pregnyl, driving market expansion.
Major players in the pregnyl market is Merck & Co. Inc.
North America was the largest region in the pregnyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pregnyl report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pregnyl market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Pregnyl is a medication that contains the hormone human chorionic gonadotropin (hCG), used in a range of medical treatments. It is prescribed to stimulate ovulation in women undergoing fertility treatments, enhance male fertility by boosting testosterone and sperm production, and treat undescended testicles in boys. The medication is administered via injection and should be used under medical supervision.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for pregnyl include fertility treatments in women, male infertility, and hypogonadotropic hypogonadism. In women, Pregnyl is primarily used to stimulate ovulation in those who face difficulties conceiving due to conditions such as polycystic ovary syndrome (PCOS) or other ovulatory disorders. Pregnyl contains hCG, which mimics the natural hormone responsible for triggering ovulation. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized by fertility clinics, research institutions, and other healthcare settings.
The pregnyl market consists of sales of pregnyl injections, hCG-based injections, and specialized hCG vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to increasing infertility rates, rising demand for assisted reproductive technologies, growing awareness of hormonal disorders, expanding healthcare access in emerging markets, rising adoption of hCG for male fertility, and rising healthcare expenditure. Major trends in the forecast period include advancements in formulation, advancements in drug delivery systems, advancements in dosage precision, innovation in combination therapies, integration of patient-friendly packaging, and adoption of telemedicine for remote fertility management.
The increasing prevalence of male hypogonadism is expected to contribute to the growth of the pregnyl market. Male hypogonadism is a condition where the body does not produce enough testosterone, a hormone crucial for male growth and development, or sufficient sperm. This condition is becoming more common due to factors such as aging populations, higher rates of obesity, and exposure to environmental toxins. Pregnyl helps manage male hypogonadism by providing human chorionic gonadotropin (hCG), which stimulates the testes to produce testosterone and support spermatogenesis, addressing hormonal imbalances, improving testosterone levels, and restoring fertility in men. For example, the Endocrine Society reported in January 2022 that approximately 35% of men over the age of 45 and 30-50% of men with obesity or type 2 diabetes experience hypogonadism. This rise in male hypogonadism is thus driving the growth of the Pregnyl market.
The increasing prevalence of infertility is also expected to drive growth in the pregnyl market. Infertility is defined as the inability to achieve pregnancy after one year of regular, unprotected intercourse. Factors such as lifestyle changes, environmental pollutants, and delayed childbearing are contributing to the growing rates of infertility. Pregnyl helps in infertility treatment by providing hCG, which stimulates ovulation in women and supports sperm production in men, enhancing reproductive function and increasing the chances of conception for those struggling with infertility. The World Health Organization reported in April 2023 that about 17.5% of the global adult population, or roughly 1 in 6 people, experience infertility. As infertility rates continue to rise, the demand for Pregnyl is expected to increase.
The expansion of healthcare infrastructure is another key factor driving the growth of the pregnyl market. Healthcare infrastructure encompasses the physical and organizational resources, facilities, and systems necessary to deliver healthcare services. This expansion is largely driven by the aging population, the rise in chronic diseases, and advancements in technology. A strong healthcare infrastructure ensures access to fertility treatments, proper storage, and administration facilities, as well as trained healthcare professionals. For example, the American Hospital Association reported in January 2024 that the United States had 6,120 hospitals with 916,752 staffed beds and 33,679,935 total admissions in 2024. In addition, the Office for National Statistics noted in May 2024 that healthcare expenditure in the UK rose by 5.6% in nominal terms from 2022 to 2023. As healthcare infrastructure continues to grow, it supports the accessibility and use of Pregnyl, driving market expansion.
Major players in the pregnyl market is Merck & Co. Inc.
North America was the largest region in the pregnyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pregnyl report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pregnyl market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Pregnyl is a medication that contains the hormone human chorionic gonadotropin (hCG), used in a range of medical treatments. It is prescribed to stimulate ovulation in women undergoing fertility treatments, enhance male fertility by boosting testosterone and sperm production, and treat undescended testicles in boys. The medication is administered via injection and should be used under medical supervision.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for pregnyl include fertility treatments in women, male infertility, and hypogonadotropic hypogonadism. In women, Pregnyl is primarily used to stimulate ovulation in those who face difficulties conceiving due to conditions such as polycystic ovary syndrome (PCOS) or other ovulatory disorders. Pregnyl contains hCG, which mimics the natural hormone responsible for triggering ovulation. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized by fertility clinics, research institutions, and other healthcare settings.
The pregnyl market consists of sales of pregnyl injections, hCG-based injections, and specialized hCG vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pregnyl Market Characteristics4. Pregnyl Market Trends And Strategies5. Pregnyl Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Pregnyl Pricing Analysis & Forecasts30. Global Pregnyl Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Pregnyl Market32. Recent Developments In The Pregnyl Market
3. Pregnyl Market Biologic Drug Characteristics
6. Global Pregnyl Growth Analysis And Strategic Analysis Framework
8. Pregnyl Market Segmentation
9. Global Pregnyl Epidemiology Of Clinical Indications
10. Pregnyl Market Regional And Country Analysis
11. Asia-Pacific Pregnyl Market
12. China Pregnyl Market
13. India Pregnyl Market
14. Japan Pregnyl Market
15. Australia Pregnyl Market
16. South Korea Pregnyl Market
17. Western Europe Pregnyl Market
18. UK Pregnyl Market
19. Germany Pregnyl Market
20. France Pregnyl Market
21. Eastern Europe Pregnyl Market
22. North America Pregnyl Market
23. USA Pregnyl Market
24. Canada Pregnyl Market
25. South America Pregnyl Market
26. Middle East Pregnyl Market
27. Africa Pregnyl Market
28. Pregnyl Market Competitive Landscape And Company Profiles
29. Global Pregnyl Market Pipeline Analysis
33. Pregnyl Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Pregnyl Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pregnyl market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pregnyl ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pregnyl market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Fertility Treatments In Women; Male Infertility; Hypogonadotropic Hypogonadism2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End-User: Fertility Clinics; Research Institutions; Other End-Users
Key Companies Profiled: Merck & Co.Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Merck & Co.Inc.
